01858.HK
Beijing Chunlizhengda Medical Instruments Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 8.29
+1.78%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 969.0M | 1.0B | 805.9M | 1.2B | 1.2B |
| Cost of Revenue | 346.6M | 392.4M | 289.4M | 332.6M | 288.1M |
| Gross Profit | 622.3M | 653.4M | 516.5M | 875.9M | 913.5M |
| Operating Expenses | |||||
| R&D Expense | 113.8M | 118.5M | 133.1M | 157.4M | 162.3M |
| SG&A Expense | 210.6M | 137.9M | 285.5M | 279.2M | 299.8M |
| General & Admin Expense | 19.6M | 12.2M | 45.3M | 9.7M | 11.0M |
| Selling & Marketing Expense | 65.8M | 125.7M | 240.2M | 269.5M | 288.9M |
| Other Expenses | 108.5M | 94.7M | (12.4M) | 133.3M | 119.0M |
| Total Operating Expenses | 337.3M | 351.2M | 406.2M | 569.9M | 581.2M |
| Cost and Expenses | 684.0M | 743.5M | 675.1M | 902.5M | 869.3M |
| Operating Income (EBIT) | 285.0M | 302.2M | 130.7M | 306.0M | 328.9M |
| Non-Operating | |||||
| Interest Income | 20.6M | 14.9M | 16.3M | 14.5M | 16.9M |
| Interest Expense | 102.9K | 200.9K | 44.9K | 364.9K | 46.7K |
| Net Interest Income | 20.5M | 14.7M | 15.3M | 14.1M | 16.6M |
| Other Non-Op Income/Expense | 20.9M | (533.4K) | 884.5K | (69.6K) | 8.0M |
| Non-Operating Income (excl Interest) | — | 32.0M | (929.4K) | (16.3K) | (8.0M) |
| EBT (Pre-Tax Income) | 305.9M | 301.7M | 131.6M | 305.9M | 336.9M |
| Income Tax Expense | 29.6M | 29.1M | 6.9M | 28.1M | 29.2M |
| Bottom Line | |||||
| Net Income | 276.3M | 272.5M | 125.0M | 277.8M | 307.7M |
| Earnings from Cont. Ops | 276.3M | 272.6M | 124.7M | 277.8M | 307.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 270.0M | 272.5M | 125.0M | 277.8M | 307.7M |
| Per Share | |||||
| Basic EPS | HK$0.70 | HK$0.71 | HK$0.33 | HK$0.72 | HK$0.80 |
| Diluted EPS | HK$0.70 | HK$0.71 | HK$0.33 | HK$0.72 | HK$0.80 |
| Revenue Per Share | HK$2.50 | HK$2.73 | HK$2.13 | HK$3.13 | HK$3.13 |
| Shares | |||||
| Basic Shares Outstanding | 388.2M | 383.3M | 378.8M | 385.9M | 383.6M |
| Diluted Shares Outstanding | 388.2M | 383.3M | 378.8M | 385.9M | 384.6M |
| Profitability Metrics | |||||
| EBITDA | 329.5M | 309.4M | 169.3M | 340.6M | 367.0M |
| D&A | 43.3M | 39.2M | 37.7M | 34.7M | 30.0M |
| EBIT | 310.0M | 270.3M | 131.6M | 306.0M | 336.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026